## QUBT: Quantum Computing Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -12.1% below STRENGTH zone (3.0-6.0%); PEG 1.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-10.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($8.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth**
- Source: Morningstar | 20251217T133219 | Bullish | Relevance: 100%
- Quantum Computing Inc. (QCi) has confirmed Dr. Yuping Huang as its Chief Executive Officer, effective January 1st, 2026, after serving as Interim CEO since April 2025. This appointment signifies QCi's transition from prototype development to industrial-scale manufacturing of its quantum photonics systems. Dr. Huang's extensive background in quantum physics and leadership roles positions QCi to accelerate its technology roadmap and expand the adoption of its room-temperature, integrated photonics quantum devices across various sectors.

**2. Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth**
- Source: PR Newswire | 20251217T133219 | Bullish | Relevance: 100%
- Quantum Computing Inc. (QCi) has confirmed Dr. Yuping Huang as its Chief Executive Officer, effective January 1st, 2026, transitioning from Interim CEO. This appointment aligns with QCi's strategy to scale its quantum photonics systems for industrial and commercial manufacturing, moving from prototype to volume production. Dr. Huang, with over 20 years in quantum physics and technology, will lead the company's growth and expansion of its room-temperature, integrated photonics quantum devices across various sectors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Cantor Fitzgera | $15 | $15 | 0% |
| 2025-12-17 | Wedbush | $12 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Cantor Fitzgera | reit | Neutral |
| 2025-12-17 | Wedbush | init | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 198.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 42.0% (+23.1%)
- Blackrock Inc.: 35.9% (+50.1%)
- Alyeska Investment G: 23.1% (+100.0%)
- Citadel Advisors Llc: 22.0% (+165.8%)
- Anson Funds Manageme: 18.5% (+14.9%)

### Key Risks

1. High beta (3.80) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-10.4% 5d) with bearish MACD, trend may be turning.
3. High short interest (22.6%, 1.5 days to cover): squeeze risk or crowded bearish bet.
4. Long-term trend broken: trading 24.3% below SMA200.
5. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.31 suggests fair value with growth premium. Balance sheet: strong liquidity (154.9x), low leverage (D/E 0.02). Revenue growth strong at 169% YoY. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.3B |
| Beta | 3.80 |
| 52W Range | $4.37 - $25.84 |
| Short Interest | 22.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.31 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from -1.7% to -12.1% (-10.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 15.1pp (needs >3.0% for momentum thesis). Underperforming sector by 11.6pp, stock-specific weakness. Below SMA200 (0.76x), long-term trend not supportive. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -12.09% (CS: 2) | Weak |
| RSI_14 | 39.0 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 0.885x | Below |
| vs SMA50 | 0.745x | Below |
| vs SMA200 | 0.757x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $10.34
- **Stop Loss:** $8.10 (21.7% risk)
- **Target:** $12.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 424
- **Position Value:** $4,384.16
- **Portfolio %:** 4.38%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-03-19 (Est: $-0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.05 | $0.07 | +239.4% |
| 2025Q2 | $-0.06 | $-0.06 | +1.2% |
| 2025Q1 | $-0.07 | $-0.05 | +29.8% |
| 2024Q4 | $-0.05 | $-0.10 | -97.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*